¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Complement C3-C5 Convertases, Classical Pathway"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
pathway
°æ·Î, Åë·Î
subthalamopallidal pathway
½Ã»ó¹ØÃ¢¹éÇÙ·Î
sensory pathway
°¨°¢·Î
ubiquitin-protease pathway
À¯ºñÄûƾ´Ü¹éºÐÇØÈ¿¼ÒÅë·Î
visual pathway
½Ã°¢°æ·Î
complement
º¸Ã¼, µµ¿òü
complement activation
º¸Ã¼È°¼ºÈ, µµ¿òüȰ¼ºÈ
complement cascade
º¸Ã¼¿¬¼â¹ÝÀÀ, µµ¿òü¿¬¼â¹ÝÀÀ
complement component
º¸Ã¼¼ººÐ, µµ¿òü¼ººÐ
complement fixation
º¸Ã¼°áÇÕ
complement fixation inhibition test
º¸Ã¼°áÇÕ¾ïÁ¦°Ë»ç
complement fixation reaction
º¸Ã¼°áÇÕ¹ÝÀÀ
complement fixation test
º¸Ã¼°áÇÕ°Ë»ç
complement inhibitor
º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
complement mediated lysis
º¸Ã¼¸Å°³¿ëÇØ, µµ¿òü¸Å°³¿ëÇØ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
subthalamopallidal pathway
½Ã»ó¹ØÃ¢¹éÇÙ·Î, ½Ã»óÇÏ´ãⱸ·Î
transcellular pathway
¼¼Æ÷Ⱦ´Ü°æ·Î
visual pathway
½Ã°¢°æ·Î
complement activation
µµ¿òüȰ¼º, º¸Ã¼È°¼º
complement-fixing antibody
µµ¿òü°áÇÕÇ×ü, º¸Ã¼°áÇÕÇ×ü
complement
µµ¿òü, º¸Ã¼
complement-induced
(¢¡complement-mediated) µµ¿òü¸Å°³-
complement-mediated
µµ¿òü¸Å°³-
complement cascade
º¸Ã¼¿¬¼âÁõÆø¹ÝÀÀ
complement component
µµ¿òü¼ººÐ
complement deficiency
µµ¿òü°áÇÌ
complement fixation
µµ¿òü°áÇÕ
complement inhibitor
º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
complement profile
µµ¿òÃ¼Ãø¸é»ó
complement receptor
µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
alternative pathway
±³´ë°æ·Î
alternative pathway
º°µµ°æ·Î, ´ëü°æ·Î
glucuronic acid pathway
±Û·çÄí·Ð»ê°æ·Î.
glycolytic pathway
ÇØ´ç°æ·Î
phosphogluconate oxidative pathway
±Û·çÄÜ»ê»êȰæ·Î, ÀÎ´ç¿ø»êȰæ·Î(ìÝÓØ ê«ß«ûùÌèÖØ).
proximal common pathway
±ÙÀ§°øÅë°æ·Î.
pyruvate pathway
ÇÇ·çºê»ê¿°´ë»ç°æ·Î(¡ß«ç¤ÓÛÞóÌèÖØ).
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
biosynthetic pathway
»ýÇÕ¼º°æ·Î(¡ÌèÖØ).
classic pathway
ÀüÇüÀû °æ·Î
coagulation,intrinsic pathway
³»ºÎ °æ·Î(ҮݻÌèÖØ)
corticastriatal pathway
ÇÇÁú¼±Á¶Ã¼°æ·Î(ù«òõàÊðÉô÷ÌèÖØ)
cyclooxygenase pathway
»çÀÌŬ·Î¿Á½Ã°Ô³ªÁ¦ ȸ·Î(¡üÞÖØ)
direct oxidative pathway
Á÷Á¢»êȰæ·Î.
dopaminergic pathway
µµÆÄ¹Î °æ·Î
extrinsic pathway
¿ÜÀμº °æ·Î.
extrinsic pathway
¿ÜÀμº °æ·Î(ÌèÖØ)
final common pathway
ÃÖÁ¾°øÅë°æ·Î.
glucuronic acid pathway
±Û·çÄí·Ð»ê°æ·Î.
glycolytic pathway
ÇØ´ç°æ·Î
intrinsic pathway
³»Àμº °æ·Î(Ò®ì×àõÌèÖØ).
lipoxygenase pathway
Áö¹æ»êÈÈ¿¼Ò°æ·Î(¡ß«ûùý£áÈÌèÖØ)
mesolimbic-mesocortical pathway
Áߺ¯¿¬°è-ÁßÇÇÁú°æ·Î(ñéÜ«æÞÍ£-ñéù«òõÌèÖØ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½